|
ZDHHC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.516400E-02 |
| Stage1-vs-Stage3 |
1.352230E-02 |
| Stage1-vs-Stage4 |
5.940700E-03 |
| Stage2-vs-Stage3 |
9.172000E-01 |
| Stage2-vs-Stage4 |
8.124400E-01 |
| Stage3-vs-Stage4 |
6.986600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.23991960932335E-12 |
| Normal-vs-Asian |
1.66144875635155E-12 |
| Caucasian-vs-AfricanAmerican |
2.912400E-01 |
| Caucasian-vs-Asian |
9.557900E-03 |
| AfricanAmerican-vs-Asian |
4.880800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.840600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.93059999945511E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.690400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.758300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.738800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.206000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.678600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.639800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.314000E-01 |
| Classical-VS-Follicular |
1.250640E-01 |
| Classical-VS-Other |
5.897800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
8.511000E-01 |
| Tall-VS-Other |
9.038600E-01 |
| Tall-VS-Normal |
5.55111512312578E-16 |
| Follicular-VS-Other |
9.861600E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
2.29819999997272E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.785200E-01 |
|
|
